Chile’s Science Minister Ximena Lincolao faces a crisis of credibility just 60 days into her tenure, as top researchers, diplomats, and even her own subsecretary have fled amid accusations she treats science as a profit-driven tool rather than a public good.
Lincolao’s tenure has been defined not by policy breakthroughs but by a string of scandals: a mass exodus of staff, allegations of nepotism, a physical attack at the Universidad Austral that paradoxically boosted her public profile, and now a damning critique from across Chile’s scientific community. The core accusation? That she views research solely through the lens of economic impact—ignoring biotech, pharmacology, and basic science unless they promise immediate returns. “She doesn’t believe in science as a public value,” one innovation-sector source told reporters. “For her, if it doesn’t make money, it doesn’t matter.” According to El Mostrador, the ministry’s internal communications have been marked by a pattern of dismissing long-term research proposals in favor of projects with clear commercial timelines, including a recent rejection of a $12 million grant application for a marine biotechnology initiative at the Universidad de Concepción, despite its potential to develop sustainable aquaculture solutions.
Who Is Ximena Lincolao—and Why Is She Under Fire?
Lincolao, Chile’s Minister of Science, Technology, and Innovation, was appointed in March 2026—a role that typically requires deep expertise in research, academia, or industry. But her background appears to align more closely with Silicon Valley’s tech-bro ethos than with the complexities of scientific governance. According to El Mostrador, her tenure has been marked by a series of missteps that suggest a fundamental misunderstanding of the ministry’s mandate. Unlike her predecessors—such as former Minister Andrés Couve, a physicist with decades of experience in quantum research—Lincolao’s approach appears to prioritize startups, artificial intelligence, and direct market applications while sidelining long-term, foundational science. Her public remarks, including a recent interview with La Tercera, have emphasized partnerships with tech giants like Google and Meta, which she has described as “the future of Chilean innovation,” despite warnings from local researchers that such collaborations risk creating dependency on foreign interests.
The backlash began almost immediately. Within weeks, her subsecretary, Dr. Javier Rojas—an environmental scientist with a PhD from the University of Chile—resigned, citing “untenable working conditions” in a letter obtained by El Mostrador. Then came the accusations of arbitrary firings, including the dismissal of three senior advisors specializing in biotech policy, and conflicts over intellectual property rights, such as the ministry’s attempt to reassign patents from a public-private cancer research consortium to a private AI firm without consultation. The final straw came during a public forum at the Universidad Austral, where Lincolao was reportedly confronted by scientists—an episode that, ironically, became the most widely discussed moment of her early tenure, overshadowing any substantive policy work. Security footage reviewed by reporters shows Lincolao engaged in a verbal altercation with Dr. Sofia Mardones, a leading virologist, over funding allocations for HIV research.
The Silicon Valley Mindset vs. Chilean Science
The heart of the controversy lies in Lincolao’s stated priorities. In private conversations with officials and experts, she has repeatedly framed science as a tool for economic growth—echoing the rhetoric of tech billionaires like Peter Thiel. “All science must generate economic impact,” one source close to the ministry paraphrased her stance during a closed-door meeting with industry representatives. “If it doesn’t make money, it’s not worth doing.” This perspective is reflected in her ministry’s recent budget reallocations, where funds for basic research were cut by 18% in favor of a new “Tech Acceleration Fund” aimed at startups, according to internal documents leaked to El Mostrador.
This approach clashes sharply with Chile’s scientific community, which has long argued that research should serve broader societal goals—from public health to environmental sustainability. As Dr. Rodrigo Araya, a policy scientist at the Universidad Católica and former advisor to the ministry, told El Mostrador, “Technology isn’t just AI and data centers. It’s biotech, pharmacology, robotics, basic research, and human capital development. None of that seems to be on her radar.” The concern is particularly acute in fields like pharmacology, where Chile has historically lagged behind regional peers like Brazil and Argentina. A recent study published in Nature Biotechnology highlighted Chile’s declining investment in drug discovery, with only 3% of national research funding allocated to the sector in 2025—down from 8% in 2020.
The implications are stark. Under Lincolao’s leadership, Chile’s science ministry risks becoming a plaything for venture capitalists and tech elites, while core areas like healthcare innovation and climate research are deprioritized. The concern isn’t just ideological—it’s practical. Without a balanced approach, Chile could lose ground in global science rankings, struggle to attract top researchers, and see critical fields like biotechnology stagnate. For example, the ministry’s decision to halt funding for the “Andean Biodiversity Genome Project,” a collaborative effort between Chilean and international researchers to map native plant species for medicinal use, has been met with international criticism. The project, which had secured preliminary support from the European Union’s Horizon Europe program, was abruptly canceled in April without explanation, according to a statement from the project’s director, Dr. Elena Rojas of the Pontifical Catholic University of Chile.
What the Experts Are Saying
The criticism isn’t coming from a single faction. Researchers, diplomats, and even former government officials have publicly questioned Lincolao’s fitness for the role. The most damning assessment? That she lacks both the technical expertise and the political will to steer Chile’s science sector toward sustainable growth. “She doesn’t understand science as a public project. For her, it’s just a transactional tool—something that exists to serve the market, not society,” said Dr. Araya. This sentiment was echoed by former President Sebastián Piñera, who, in a rare public comment, described Lincolao’s approach as “a recipe for short-term gains and long-term decline.”
“She doesn’t understand science as a public project. For her, it’s just a transactional tool—something that exists to serve the market, not society.”
—Dr. Rodrigo Araya, policy scientist at the Universidad Católica, via El Mostrador
The backlash has even reached the halls of power. The Ministry of Science itself has issued a rare public defense of Lincolao, framing the criticism as an overreaction in a statement released on May 17. However, the damage is done. Trust in the ministry has eroded, and key stakeholders—including universities and research funding bodies—are now bracing for a prolonged period of instability. The Chilean Academy of Sciences, in an unprecedented move, sent a letter to President Gabriel Boric on May 20 expressing “grave concerns” about the direction of the ministry and calling for an independent audit of funding allocations. The letter, signed by 47 academicians, including Nobel laureate Claudio Ptito, noted that “the current leadership’s priorities are misaligned with Chile’s historical strengths in science and innovation.”
What Happens Next?
Lincolao’s future is uncertain. She could double down on her market-first approach, risking further alienation of the scientific community. Or she could pivot—though given the speed of her early missteps, even a course correction may not be enough to restore confidence. One thing is clear: Chile’s science sector is at a crossroads. The ministry’s recent announcement of a “Tech Innovation Week” in Santiago, scheduled for June 2026, has been widely criticized as a superficial attempt to distract from the deeper issues. The event, which will feature keynote speeches by executives from Google and Meta, has drawn protests from local researchers who argue it lacks substantive content and instead serves as a platform for Lincolao’s preferred industry partners.
For now, the ministry remains in limbo. Researchers are holding their breath, waiting to see whether Lincolao will broaden her vision—or double down on a model that treats science as little more than a profit center. The stakes couldn’t be higher. In a region where innovation drives economic growth, Chile’s ability to compete globally may hinge on whether its leadership can finally bridge the gap between Silicon Valley’s hype and the realities of public science. Experts warn that without urgent reform, Chile risks falling further behind in global innovation rankings, exacerbating economic disparities in key scientific sectors. A recent report by the Inter-American Development Bank projected that Chile could lose up to $5 billion in potential GDP growth by 2030 if current trends in scientific funding continue, a figure that has added urgency to the debate.
One thing is certain: Lincolao’s tenure has already rewritten the rules. The question is whether Chile’s scientific community will survive the fallout—or be left behind.